Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 8Lymphoma, T-Cell, Cutaneous 6Leukemia, Lymphocytic, Chronic, B-Cell 6Lymphoma, T-Cell, Peripheral 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Follicular 4Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Drug-Related Side Effects and Adverse Reactions 2Waldenstrom Macroglobulinemia 1Recurrence 1Neoplasms by Histologic Type 1Neoplasms 1Mastocytosis, Systemic 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphatic Diseases 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Mast-Cell 1Immunoblastic Lymphadenopathy 1

Interventions

Cyclophosphamide 8fludarabine 4Rituximab 4Melphalan 3tetulomab tetraxetan lu-177 2ponatinib 2fludarabine phosphate 2entrectinib 2atezolizumab 2alectinib 2Whole-Body Irradiation 2Vincristine 2Tacrolimus 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Lutetium 2Etoposide 2Doxorubicin 2Busulfan 2Brentuximab Vedotin 2Bortezomib 2Bone Marrow Transplantation 2trametinib 1pertuzumab 1penpulimab 1pembrolizumab 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × denileukin diftitox × Lymphoid × Clear all
NCT01401530 2018-11-23

E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma

Eisai Inc.

Phase 1 Completed
13 enrolled 18 charts
Lymphoid

Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡